KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
1-Year Est. Return 19.71%
This Quarter Est. Return
1 Year Est. Return
+19.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$181M
AUM Growth
+$11.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
15
New
Increased
Reduced
Closed

Top Buys

1
+$14.1M
2
+$10.5M
3
+$7.44M
4
UTHR icon
United Therapeutics
UTHR
+$1.9M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$1.72M

Top Sells

1
+$16.7M
2
+$3.22M
3
+$2.77M
4
ALKS icon
Alkermes
ALKS
+$1M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$633K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$10.7B
$32.4M 17.93%
878,533
-87,333
UTHR icon
2
United Therapeutics
UTHR
$18.6B
$30.3M 16.74%
98,228
+6,171
CAH icon
3
Cardinal Health
CAH
$38.7B
$26M 14.38%
188,745
-20,100
SUPN icon
4
Supernus Pharmaceuticals
SUPN
$2.93B
$14.1M 7.82%
+431,986
JAZZ icon
5
Jazz Pharmaceuticals
JAZZ
$8.39B
$12.5M 6.91%
100,703
-5,100
ENTA icon
6
Enanta Pharmaceuticals
ENTA
$301M
$11.7M 6.46%
2,116,586
-804
GSK icon
7
GSK
GSK
$88B
$10.5M 5.83%
+272,000
INDV icon
8
Indivior
INDV
$3.07B
$9.2M 5.09%
965,368
+29,688
SNY icon
9
Sanofi
SNY
$124B
$8.27M 4.57%
149,096
-100
BNTX icon
10
BioNTech
BNTX
$25.6B
$7.97M 4.41%
87,563
-1,100
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.81B
$7.44M 4.11%
+950,000
ALKS icon
12
Alkermes
ALKS
$5.01B
$6.86M 3.79%
207,822
-30,314
VNDA icon
13
Vanda Pharmaceuticals
VNDA
$332M
$3.46M 1.91%
754,381
+375,619
MURA icon
14
Mural Oncology
MURA
$36.4M
$89K 0.05%
70,263
+100
BIIB icon
15
Biogen
BIIB
$21.9B
– –
-108,923